Ten years' disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy A case report and literature review

被引:2
|
作者
Zhang, Jue [1 ]
Mei, Liejun [2 ]
Wang, Fubing [3 ]
Li, Yan [1 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Peritoneal Canc Surg, 10 Tieyi Rd,Yangfangdian St, Beijing 100038, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Dept Radiol, Wuhan 430071, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Dept Clin Lab, Wuhan 430071, Peoples R China
基金
北京市自然科学基金;
关键词
advanced ovarian cancer; cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; peritoneal carcinomatosis; HIPEC; PACLITAXEL; CISPLATIN;
D O I
10.1097/MD.0000000000023404
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: One of the most distinctive features of epithelial ovarian cancer is tendency to disseminate into peritoneal cavity to form peritoneal carcinomatosis, indicating advanced disease with poor prognosis. Patient concerns: A fifty-year-old patient had a chief complaint of an abdominal distension lasting 1 month. Diagnoses: The patient was diagnosed with advanced epithelial ovarian cancer with peritoneal carcinomatosis by computed tomography scan, tumor markers, endoscopy examination, and pathology. Interventions: The patient was treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy followed by 8 cycles of systemic chemotherapy. Outcomes: Till March 9, 2020, the patient has disease-free survival over 10 years. Lessons: The application of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy combined with systematic chemotherapy may improve survival dramatically for the patients with epithelial ovarian cancer and peritoneal carcinomatosis and should be considered as an option of a relatively new regime.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Cytoreductive Surgery Plus Platinum-Based Hyperthermic Intraperitoneal Chemotherapy in Epithelial Ovarian Cancer: A Promising Integrated Approach to Improve Locoregional Control
    Petrillo, Marco
    Anchora, Luigi Pedone
    Scambia, Giovanni
    Fagotti, Anna
    ONCOLOGIST, 2016, 21 (05) : 532 - 534
  • [42] Peritoneal metastasis of advanced epithelial ovarian carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective international multicentric data analysis
    Torun, Bahar Canbay
    Glehen, Olivier
    Kepenekian, Vahan
    Sardi, Armando
    Arjona-Sanchez, Alvaro
    Yonemura, Yutaka
    Barat, Shoma
    Morris, David
    Spiliotis, John
    Coccolini, Federico
    Sommariva, Antonio
    Bartos, Adrian
    Raza, Sayyed
    Vander Speteen, Kurt
    Akin, Levhi
    Irez, Tulay
    Canbay, Emel
    EJSO, 2023, 49 (08): : 1489 - 1494
  • [43] A rare case of recurrent epidermoid anal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy—case report
    Vera Pravong
    Alexandre Brind’Amour
    Lucas Sidéris
    Pierre Dubé
    Jean-François Tremblay
    World Journal of Surgical Oncology, 18
  • [44] Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Management of Advanced Ovarian Cancer. A Literature Review
    Ghirardi, Valentina
    Trozzi, Rita
    Giudice, Elena
    Scambia, Giovanni
    Fagotti, Anna
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2022, 43 (02) : 335 - 340
  • [45] Ascites do not affect the rate of complete cytoreductive surgery and prognosis in patients with primary ovarian cancer with ascites treated with hyperthermic intraperitoneal chemotherapy
    Ba, Mingchen
    Long, Hui
    Zhang, Xiangliang
    Yan, Zhaofei
    Wang, Shuai
    Wu, Yinbing
    Gong, Yuanfeng
    Cui, Shuzhong
    ONCOLOGY LETTERS, 2019, 18 (02) : 2025 - 2033
  • [46] Primary Peritoneal Rhabdomyosarcomatosis in a 2-Year-Old Child Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy — Case Report and Review of Literature
    Mufaddal Kazi
    Sajid S. Qureshi
    Indian Journal of Surgical Oncology, 2021, 12 : 322 - 326
  • [47] Primary Peritoneal Rhabdomyosarcomatosis in a 2-Year-Old Child Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Case Report and Review of Literature
    Kazi, Mufaddal
    Qureshi, Sajid S.
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2021, 12 (SUPPL 2) : 322 - 326
  • [49] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves the survival of gastric cancer patients with ovarian metastasis and peritoneal dissemination
    Wu, Xiao-Jiang
    Yuan, Peng
    Li, Zi-Yu
    Bu, Zhao-De
    Zhang, Lian-Hai
    Wu, Ai-Wen
    Zong, Xiang-Long
    Li, Shuang-Xi
    Shan, Fei
    Ji, Xin
    Ren, Hui
    Ji, Jia-Fu
    TUMOR BIOLOGY, 2013, 34 (01) : 463 - 469
  • [50] Risk factors for postoperative delayed gastric emptying in ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Guang-Xia Cui
    Zi-Jun Wang
    Jin Zhao
    Ping Gong
    Shuai-Hong Zhao
    Xiao-Xue Wang
    Wen-Pei Bai
    Yan Li
    World Journal of Clinical Cases, 2021, 9 (18) : 4644 - 4653